Collaborative intelligence to transform healthcare services digitally.
Lantheus to buy radiopharma CDMO and diagnostic assets for $250M upfront
In its latest move to expand its portfolio, Lantheus Holdings is spending $250 million upfront to buy radiopharma CDMO and diagnostics company Evergreen Theragnostics, which